Catecholaminergic polymorphic ventricular tachycardia

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1044-52. doi: 10.1161/CIRCEP.111.962027. Epub 2012 Sep 27.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Animals
  • Anti-Arrhythmia Agents / therapeutic use
  • Calsequestrin / genetics
  • Defibrillators, Implantable
  • Electrocardiography
  • Flecainide / therapeutic use
  • Humans
  • Mutation
  • Phenotype
  • Ryanodine Receptor Calcium Release Channel / genetics
  • Sympathectomy
  • Tachycardia, Ventricular / diagnosis
  • Tachycardia, Ventricular / genetics*
  • Tachycardia, Ventricular / physiopathology
  • Tachycardia, Ventricular / therapy
  • Verapamil / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • CASQ2 protein, human
  • Calsequestrin
  • Ryanodine Receptor Calcium Release Channel
  • casq2 protein, mouse
  • Verapamil
  • Flecainide

Supplementary concepts

  • Polymorphic catecholergic ventricular tachycardia